BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect.
about
BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North AfricanA novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing.Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases.Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian populationFounder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.Impact of germline and somatic BRCA1/2 mutations: tumor spectrum and detection platforms.Mutations in context: implications of BRCA testing in diverse populations.GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in and Pathogenic Variant Carriers
P2860
Q27002334-26CE1DE4-2F58-458D-911C-A004427C281DQ33214483-0056AFC1-1125-4734-8053-DEC9678E036EQ34530426-B2FA39E8-EDE3-4E53-8E48-E360544C0AF8Q35630889-A12573F4-E267-403D-92E3-C8BE55A7CBE7Q35645650-0C14E095-B16C-4D3A-91C2-98E6A9BE33AFQ36117690-4C41A3C6-6030-4D0E-8920-54CF95573457Q38685296-973661B1-B66D-4200-A531-4C903829A068Q42181679-8E0E87D0-6A8A-4B76-BFED-CF4B8CD0E86BQ45870377-C20CA628-AFD2-4ADD-8E4A-14137155D3A8Q47691368-2A700708-6919-4022-A8D4-D5CB794F396FQ59138109-85CBE15A-34F1-4AE0-8A78-67237C0CDDBF
P2860
BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
BRCA1 testing in breast and/or ...... tations with a founder effect.
@ast
BRCA1 testing in breast and/or ...... tations with a founder effect.
@en
BRCA1 testing in breast and/or ...... tations with a founder effect.
@nl
type
label
BRCA1 testing in breast and/or ...... tations with a founder effect.
@ast
BRCA1 testing in breast and/or ...... tations with a founder effect.
@en
BRCA1 testing in breast and/or ...... tations with a founder effect.
@nl
prefLabel
BRCA1 testing in breast and/or ...... tations with a founder effect.
@ast
BRCA1 testing in breast and/or ...... tations with a founder effect.
@en
BRCA1 testing in breast and/or ...... tations with a founder effect.
@nl
P2093
P1433
P1476
BRCA1 testing in breast and/or ...... tations with a founder effect.
@en
P2093
Catherine Bonaiti-Pellié
Danièle Muller
Jean-Pierre Fricker
Joseph Abecassis
P356
10.1023/B:FAME.0000026819.44213.DF
P577
2004-01-01T00:00:00Z
P6179
1043803999